Mayne Pharma Group's book value per share for the quarter that ended in Dec. 2025 was $2.89.
During the past 12 months, Mayne Pharma Group's average Book Value Per Share Growth Rate was -21.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -10.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -16.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -7.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Mayne Pharma Group was 51.10% per year. The lowest was -24.20% per year. And the median was 7.80% per year.
Mayne Pharma Group's current price is $1.9726. Its book value per share for the quarter that ended in Dec. 2025 was $2.89. Hence, today's PB Ratio of Mayne Pharma Group is 0.66.
During the past 13 years, the highest P/B Ratio of Mayne Pharma Group was 4.68. The lowest was 0.38. And the median was 0.77.
Mayne Pharma Group (OTCPK:MAYNF) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Mayne Pharma Group Book Value per Share Related Terms
Mayne Pharma Group Book Value per Share Historical Data
* Premium members only.
The historical data trend for Mayne Pharma Group's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MAYNF vs MCK, CAH, COR: Book Value per Share Comparison
For the Medical Distribution subindustry, Mayne Pharma Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mayne Pharma Group PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Mayne Pharma Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Mayne Pharma Group's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mayne Pharma Group (MAYNF) has a Book Value per Share of $2.89 as of Dec. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Mayne Pharma Group and its competitors.
Is Mayne Pharma Group's Book Value per Share too high?
Mayne Pharma Group's current Book Value per Share is $2.89. Overall, Mayne Pharma Group has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mayne Pharma Group's Book Value per Share compare to MCK and CAH?
Mayne Pharma Group's Book Value per Share of $2.89 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Distribution company?
A good Book Value per Share depends on the Medical Distribution industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Mayne Pharma Group and its competitors. Mayne Pharma Group's current Book Value per Share is $2.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mayne Pharma Group stock overvalued right now?
Based on GuruFocus' analysis, Mayne Pharma Group (MAYNF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.57, compared to a current price of $1.97 — trading 44.7% below its estimated fair value. The current Book Value per Share is $2.89. Mayne Pharma Group's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Mayne Pharma Group (MAYNF), the current Book Value per Share is $2.89 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mayne Pharma Group (MAYNF) Overvalued in 2026?
Based on GuruFocus' analysis, Mayne Pharma Group stock appears to be undervalued.
The current stock price of $1.97 is trading 44.7% below its estimated GF Value™ of $3.57.
GuruFocus considers Mayne Pharma Group to be Possible Value Trap.
Key valuation signals for MAYNF:
Book Value per Share: $2.89
GF Value™: $3.57 vs. price of $1.97 (44.7% below fair value)
No single metric tells the full story. See the MAYNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.
52GF Score
Get the complete analysis for MAYNF
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAYNF has been successfully added to your 
